Last reviewed · How we verify
venipunctures
At a glance
| Generic name | venipunctures |
|---|---|
| Sponsor | Centre Hospitalier Universitaire Dijon |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Cellular Mechanisms for Metabolic Dysfunction in HIV (Phase 1)
- Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (N/A)
- Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions (Phase 4)
- Expression of PARP-1 in Optic Neuritis of Multiple Sclerosis Patients (NA)
- ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer (EARLY/Phase 1)
- Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay (NA)
- Biological-guided Development and Validation of Specific Cognitive Assessment Instruments in Huntington's Disease (N/A)
- A Phase 2, Single-Arm, Multi-center Study of 177Lu-PSMA (177Lu-PNT2002) in Patients With PSMA-Positive Adenoid Cystic Carcinoma (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- venipunctures CI brief — competitive landscape report
- venipunctures updates RSS · CI watch RSS
- Centre Hospitalier Universitaire Dijon portfolio CI